share_log

奥本海默:重申Relay Therapeutics(RLAY.US)评级,由优于大市调整至优于大市评级, 目标价由33.00美元调整至25.00美元。

Zhitong Finance ·  May 6 08:06

奥本海默:重申Relay Therapeutics(RLAY.US)评级,由优于大市调整至优于大市评级, 目标价由33.00美元调整至25.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment